Search filters

List of works by Michael A. Curran

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

scientific article (publication date: November 2016)

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016

scientific article published oln 16 November 2016

4-1BB Agonists: Multi-Potent Potentiators of Tumor Immunity

scientific article

CTLA4 blockade and GM-CSF combination immunotherapy alters the intratumor balance of effector and regulatory T cells

scientific article published on 15 June 2006

Combination CTLA-4 blockade and 4-1BB activation enhances tumor rejection by increasing T-cell infiltration, proliferation, and cytokine production

scientific article (publication date: 29 April 2011)

Editorial: Advances in Combination Tumor Immunotherapy

scientific article

Efficient transduction of nondividing cells by optimized feline immunodeficiency virus vectors.

scientific article published on January 2000

Expression from second-generation feline immunodeficiency virus vectors is impaired in human hematopoietic cells

scientific article published in November 2002

Gene therapy-mediated reprogramming tumor infiltrating T cells using IL-2 and inhibiting NF-κB signaling improves the efficacy of immunotherapy in a brain cancer model

scientific article

Hypoxic stress: obstacles and opportunities for innovative immunotherapy of cancer

scientific article published on 27 June 2016

Immune checkpoint combinations from mouse to man.

scientific article published on 03 January 2015

Immune rejection of mouse tumors expressing mutated self.

scientific article published on 7 April 2009

Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity.

scientific article

Ipilimumab with Stereotactic Ablative Radiation Therapy: Phase I Results and Immunologic Correlates from Peripheral T Cells

scientific article

Lentiviral vectors for the delivery of DNA into mammalian cells.

scientific article published on January 2004

PD-1 and CTLA-4 combination blockade expands infiltrating T cells and reduces regulatory T and myeloid cells within B16 melanoma tumors

scientific article (publication date: 2 March 2010)

Prolonged liver-specific transgene expression by a non-primate lentiviral vector

scientific article published on July 2004

Prolonged transgene expression in murine salivary glands following non-primate lentiviral vector transduction

scientific article

Protection of human pancreatic islets using a lentiviral vector expressing two genes: cFLIP and GFP.

scientific article published in January 2008

Repertoire enhancement with adoptively transferred female lymphocytes controls the growth of pre-implanted murine prostate cancer

scientific article

Response to "Ipilimumab (Yervoy) and the TGN1412 catastrophe".

scientific article

Role of the tumor microenvironment in mature B-cell lymphoid malignancies

scientific article

Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin

scientific article published on April 2013

TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma

scientific article published on 26 November 2019

Tumor vaccines expressing flt3 ligand synergize with ctla-4 blockade to reject preimplanted tumors

scientific article published on 8 September 2009

Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.

scientific article